Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development expenses		$ 11,821	$ 19,494
General and administrative expenses		11,888	14,944
Manufacturing services		3,527	0
Total operating expenses		27,236	34,438
Loss from operations		(27,236)	(34,438)
Other income (expense):
Gain on sale of VOWST Business		52,181	0
Interest income		618	1,648
Interest expense		0	(618)
Other income	[1]	7,119	505
Total other income, net		59,918	1,535
Net income (loss) from continuing operations		32,682	(32,903)
Net (loss) from discontinuing operations, net of tax		0	(7,230)
Net income (loss)		$ 32,682	$ (40,133)
Net income (loss) from continuing operations per share attributable to common stockholders - basic		$ 3.76	$ (4.5)
Net (loss) from discontinued operations per share attributable to common stockholders - basic		0	(0.99)
Net income (loss) per share attributable to common stockholders - basic		3.76	(5.49)
Net income (loss) from continuing operations per share attributable to common stockholders - diluted		3.75	(4.5)
Net (loss) from discontinuing operations attributable to common stockholders - diluted		0	(0.99)
Net income (loss) per share attributable to common stockholders - diluted		$ 3.75	$ (5.49)
Weighted average common shares outstanding - basic		8,703,221	7,305,026
Weighted average common shares outstanding - diluted		8,714,701	7,305,026

[1] Includes $6,309 for the three months ended March 31, 2025 related to reimbursement received from SPN (related party) for transition services provided by the Company.